BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33630469)

  • 21. Fragmented care, Commission on Cancer accreditation, and overall survival in patients receiving surgery and chemotherapy for esophageal cancer.
    Verm RA; Baker MM; Cohn T; Park S; Swanson J; Freeman R; Abdelsattar ZM
    Surgery; 2024 Mar; 175(3):618-628. PubMed ID: 37743107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan.
    Tsukada Y; Higashi T; Shimada H; Kikuchi Y; Terahara A
    Int J Clin Oncol; 2018 Feb; 23(1):81-91. PubMed ID: 28795280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of Care in Neoadjuvant Chemoradiotherapy for Node-Positive Esophageal Adenocarcinoma.
    Raman V; Jawitz OK; Voigt SL; Rhodin KE; Kim AW; Tong BC; D'Amico TA; Harpole DH
    Ann Thorac Surg; 2020 Dec; 110(6):1832-1839. PubMed ID: 32622794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A National Analysis of Treatment Patterns and Outcomes for Patients 80 Years or Older With Esophageal Cancer.
    Yang CJ; Wang Y; Raman V; Patel D; Lui N; Backhus L; Shrager J; Berry MF; Liou D
    Semin Thorac Cardiovasc Surg; 2021; 33(3):884-892. PubMed ID: 32977014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database.
    Vlacich G; Samson PP; Perkins SM; Roach MC; Parikh PJ; Bradley JD; Lockhart AC; Puri V; Meyers BF; Kozower B; Robinson CG
    Cancer Med; 2017 Dec; 6(12):2886-2896. PubMed ID: 29139215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definitive chemoradiotherapy has comparable survival outcomes to esophagectomy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: real-world data.
    Sawada K; Kotani D; Yukami H; Mishima S; Fujiwara H; Kadota T; Nakajo K; Yoda Y; Nakamura M; Hojo H; Yano T; Fujita T; Kojima T
    Int J Clin Oncol; 2022 Aug; 27(8):1279-1288. PubMed ID: 35779118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoradiotherapy and radiotherapy alone in patients with esophageal cancer aged 80 years or older based on the Comprehensive Registry of Esophageal Cancer in Japan.
    Jingu K; Numasaki H; Toh Y; Nemoto K; Uno T; Doki Y; Matsubara H
    Esophagus; 2020 Jul; 17(3):223-229. PubMed ID: 32088786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early vs Delayed Surgery for Esophageal Cancer During the COVID-19 Pandemic.
    Bajaj SS; Shah KM; Potter AL; Mayne NR; Sachdeva UM; Lin MW; Yang CJ
    J Am Coll Surg; 2022 Aug; 235(2):174-184. PubMed ID: 35839391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive registry of esophageal cancer in Japan, 2013.
    Watanabe M; Tachimori Y; Oyama T; Toh Y; Matsubara H; Ueno M; Kono K; Uno T; Ishihara R; Muro K; Numasaki H; Tanaka K; Ozawa S; Murakami K; Usune S; Takahashi A; Miyata H;
    Esophagus; 2021 Jan; 18(1):1-24. PubMed ID: 33047261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
    Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
    J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consequences of Refusing Surgery for Esophageal Cancer: A National Cancer Database Analysis.
    Rahouma M; Harrison S; Kamel M; Nasar A; Lee B; Port J; Altorki N; Stiles B
    Ann Thorac Surg; 2018 Nov; 106(5):1476-1483. PubMed ID: 30055137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimally invasive esophagectomy provides significant survival advantage compared with open or hybrid esophagectomy for patients with cancers of the esophagus and gastroesophageal junction.
    Palazzo F; Rosato EL; Chaudhary A; Evans NR; Sendecki JA; Keith S; Chojnacki KA; Yeo CJ; Berger AC
    J Am Coll Surg; 2015 Apr; 220(4):672-9. PubMed ID: 25667145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal Cancer.
    Voncken FEM; van der Kaaij RT; Sikorska K; van Werkhoven E; van Dieren JM; Grootscholten C; Snaebjornsson P; van Sandick JW; Aleman BMP
    Am J Clin Oncol; 2018 Sep; 41(9):919-926. PubMed ID: 28763327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Chemoradiation-induced Myelosuppression on Prognosis of Patients with Locally Advanced Esophageal Cancer After Chemoradiotherapy Followed by Esophagectomy.
    Ohira M; Kubo N; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Hirakawa K
    Anticancer Res; 2015 Sep; 35(9):4889-95. PubMed ID: 26254384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
    Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive registry of esophageal cancer in Japan, 2014.
    Watanabe M; Toh Y; Ishihara R; Kono K; Matsubara H; Murakami K; Muro K; Numasaki H; Oyama T; Ozawa S; Saeki H; Tanaka K; Tsushima T; Ueno M; Uno T; Yoshio T; Usune S; Takahashi A; Miyata H;
    Esophagus; 2022 Jan; 19(1):1-26. PubMed ID: 34550491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Definitive Chemoradiotherapy Compared to Neoadjuvant Chemoradiotherapy With Esophagectomy for Locoregional Esophageal Cancer: National Population-based Cohort Study.
    Kamarajah SK; Phillips AW; Hanna GB; Low D; Markar SR
    Ann Surg; 2022 Mar; 275(3):526-533. PubMed ID: 32865948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study.
    Wani S; Drahos J; Cook MB; Rastogi A; Bansal A; Yen R; Sharma P; Das A
    Gastrointest Endosc; 2014 Feb; 79(2):224-232.e1. PubMed ID: 24060519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.